Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain).: Rationale for universal vaccination programmes

被引:49
作者
Salleras, L
Domínguez, A
Vidal, J
Plans, P
Salleras, M
Taberner, JL
机构
[1] Autonomous Govt Catalonia, Dept Hlth & Social Secur, Gen Directorate Publ Hlth, Catalonia, Spain
[2] Hosp Clin Barcelona, Microbiol Unit, Barcelona, Spain
[3] Hosp Sagrat Cor, Dermatol Unit, Barcelona, Spain
关键词
varicella-zoster virus; varicella antibodies; seroprevalence survey; universal vaccination;
D O I
10.1016/S0264-410X(00)00178-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
With the aim of designing a strategy for vaccination against varicella-zoster virus (VZV), the results of a seroepidemiological survey on VZV infection carried out in a sample of the population of Catalonia are presented. Representative samples from schoolchildren (30 schools) and adults (97 municipal areas) were obtained by random cluster sampling. In the study, 883 children and 1253 adults were included. Age, gender, place of birth, place of residence, educational level and occupation were investigated in the study subjects. An ELISA test was used to measure varicella antibodies. The prevalence of varicella antibodies increased with age, being 85% in the 5-9 years age group, 92% in the 10-14 years age group, 94% in the 15-34 years age group and almost 100% in people over 35. No association was found between sociodemographic variables studied and prevalence levels of antibodies. These results suggest that the best vaccination strategy in Catalonia would be to add a temporary vaccination programme of pre-adolescents at 12 years to routine vaccination at 15 months. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 46 条
[1]  
*ADV COMM IMM PRAC, 1999, MMWR-MORBID MORTAL W, V48, pRR6
[2]   Varicella vaccine: The Japanese experience [J].
Asano, Y .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 :S310-S313
[3]  
BRUNELL PA, 1986, PEDIATRICS, V77, P53
[4]   THE EPIDEMIOLOGY OF VARICELLA AND ITS COMPLICATIONS [J].
CHOO, PW ;
DONAHUE, JG ;
MANSON, JE ;
PLATT, R .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) :706-712
[5]   Recent advances in varicella-zoster virus infection [J].
Cohen, JI ;
Brunell, PA ;
Straus, SE ;
Krause, PR .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (11) :922-932
[6]  
Comm Infect Dis, 2000, PEDIATRICS, V105, P136
[7]   IMMUNITY TO WHOLE VARICELLA-ZOSTER VIRUS-ANTIGEN AND GLYCOPROTEIN-I AND GLYCOPROTEIN-P170 - RELATION TO THE IMMUNIZING REGIMEN OF LIVE ATTENUATED VARICELLA VACCINE [J].
DIAZ, PS ;
SMITH, S ;
HUNTER, E ;
ARVIN, AM .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) :1245-1252
[8]   SEROEPIDEMIOLOGY OF VARICELLA IN CHILDREN FROM SPAIN [J].
EGUILUZ, GC ;
TRALLERO, EP ;
ARENZANA, JMG .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (05) :851-851
[9]   Varicella-Zoster virus epidemiology - A changing scene? [J].
Fairley, CK ;
Miller, E .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 :S314-S319
[10]   ANOTHER VACCINE, ANOTHER TREADMILL [J].
FERSON, MJ .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1995, 31 (01) :3-5